Strategic Science & Technologies, LLC   Report issue

For profit Phase 2 Phase 3
Founded: Cambridge MA United States (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2013
NCT01874626
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Strategic Science & Technologies, LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

ibuprofen (motrin) (4 trials)

Drugs in Phase 2 Trials (1)

sildenafil (viagra) (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ankle Injuries (Phase 3)

Erectile Dysfunction (Phase 2)

Myalgia (Phase 3)

Sexual Dysfunctions, Psychological (Phase 2)

Sprains and Strains (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 2